Baricitinib
An orally available small molecule drug with potential anti-inflammatory, immunomodulating, antineoplastic and antiviral activities. Baricitinib is a globally approved treatment for rheumatoid arthritis.
All edits by GUSTAVO MACEDO
Edits on 21 Nov, 2020
GUSTAVO MACEDO
Edits made to:
Article (+13/-13 characters)
Article
Image source: National Center for BiotechnologyBiotechnology Information
Find more entities like Baricitinib
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.